These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A critical synopsis of the diagnostic and screening radiology outcomes literature. Blackmore CC; Black WC; Jarvik JG; Langlotz CP Acad Radiol; 1999 Jan; 6 Suppl 1():S8-18. PubMed ID: 9891161 [TBL] [Abstract][Full Text] [Related]
23. Cost and effectiveness: approval and payment for Pulverizer. Riegelman R Md Med; 2002; 3(3):50-4. PubMed ID: 12214498 [No Abstract] [Full Text] [Related]
24. The limits of cost-effectiveness analysis. Weintraub WS; Cohen DJ Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):55-8. PubMed ID: 20031813 [No Abstract] [Full Text] [Related]
25. Cost-effectiveness and cost-benefit analysis of health services: the methodology and its application. Griffiths A Health Policy; 1988; 9(3):251-65. PubMed ID: 10312550 [TBL] [Abstract][Full Text] [Related]
27. Developments and outcomes in Australian diagnostic imaging services. Hailey DM Acad Radiol; 1996 Apr; 3 Suppl 1():S92-4. PubMed ID: 8796526 [No Abstract] [Full Text] [Related]
28. [Effectiveness and cost effectiveness of innovative medical techniques in public health]. Stehr H Radiologe; 1996 Apr; 36(4):279-84. PubMed ID: 8677319 [TBL] [Abstract][Full Text] [Related]
29. Investment in health care innovation. Pollard MR; Persinger GS Health Aff (Millwood); 1987; 6(2):93-106. PubMed ID: 3114113 [No Abstract] [Full Text] [Related]
30. The impact of business cycles on imaging services and technology. Papatheofanis FJ Adm Radiol J; 1998 Apr; 17(4):28-9. PubMed ID: 10181528 [No Abstract] [Full Text] [Related]
31. Care to compare? Aston G Hosp Health Netw; 2008 Dec; 82(12):38-41, 1. PubMed ID: 19209502 [TBL] [Abstract][Full Text] [Related]
32. The expanded role of randomized clinical trials. Kupfer C Am J Ophthalmol; 1996 Dec; 122(6):883-5. PubMed ID: 8956644 [No Abstract] [Full Text] [Related]
33. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States. Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730 [TBL] [Abstract][Full Text] [Related]
34. Technology assessment and public health. Power EJ; Tunis SR; Wagner JL Annu Rev Public Health; 1994; 15():561-79. PubMed ID: 8054099 [No Abstract] [Full Text] [Related]
35. Willingness to pay in the context of an economic evaluation of healthcare programs: theory and practice. Gafni A Am J Manag Care; 1997 May; 3 Suppl():S21-32. PubMed ID: 10180338 [TBL] [Abstract][Full Text] [Related]
36. Clinical and economic outcomes assessment in nuclear cardiology. Shaw LJ; Miller DD; Berman DS; Hachamovitch R Q J Nucl Med; 2000 Jun; 44(2):138-52. PubMed ID: 10967624 [TBL] [Abstract][Full Text] [Related]
37. Biomedical imaging symposium: visualizing the future of biology and medicine. Sullivan DC Radiology; 2000 Jun; 215(3):634-8. PubMed ID: 10831677 [No Abstract] [Full Text] [Related]
38. National Cancer Institute partnerships with Academia and Industry in Cancer Diagnosis and Treatment: report of the workshop. Zerhouni EA; Plewes D; Vosburgh KG Acad Radiol; 1998 Feb; 5(2):133-40. PubMed ID: 9484548 [No Abstract] [Full Text] [Related]
39. The imperative to improve. Pashos CL Value Health; 2009; 12(8):1084-5. PubMed ID: 20667065 [No Abstract] [Full Text] [Related]
40. Technology assessment: a perspective from the National Cancer Institute. Shtern F Acad Radiol; 1996 Apr; 3 Suppl 1():S84-7. PubMed ID: 8796524 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]